Factor 4, composed of long chain dicarboxylacylcarnitines (LCDA), was also associated with change in NT pro-BNP and was the only factor that was predictive of clinical outcomes (time to death or HF hospitalization), a finding that was stronger in individuals with T2DM. Here, NPPB is linked to type 2 diabetes mellitus.